,X,Filing Date,Trade Date,Ticker,Insider Name,Title,Trade Type,Price,Qty,Owned,ΔOwn,Value,1d,1w,1m,6m,ticker
0,,2021-06-29 17:09:26,2021-06-25,XOMA,Neal James R,CEO,S - Sale,$33.62,-9027,32788,-22%,"-$303,474",,,,,XOMA
1,,2021-04-13 16:30:19,2021-04-09,XOMA,Neal James R,CEO,A - Grant,$25.00,8000,41815,+24%,"+$200,000",,,,,XOMA
2,,2021-04-13 16:30:17,2021-04-09,XOMA,Burns Thomas M.,"SVP, Finance, CFO",A - Grant,$25.00,1000,13458,+8%,"+$25,000",,,,,XOMA
3,D,2021-04-02 17:19:46,2021-03-31,XOMA,Bvf Partners L P/il,"See Remarks, 10%",S - Sale+OE,$38.36,-651700,437061,-60%,"-$24,999,212",,,,,XOMA
4,D,2021-03-16 16:30:28,2021-03-15,XOMA,Van Ness W Denman,Dir,M - OptEx,$10.41,5699,15644,+57%,"+$59,332",,,,,XOMA
5,D,2020-12-17 16:30:23,2020-12-15,XOMA,Neal James R,CEO,A - Grant,$25.00,8000,33522,+31%,"+$200,000",,,,,XOMA
6,D,2020-12-17 16:30:23,2020-12-15,XOMA,Neal James R,CEO,M - OptEx,$5.50,26000,33522,+346%,"+$143,000",,,,,XOMA
7,D,2020-12-17 16:30:23,2020-12-15,XOMA,Neal James R,CEO,S - Sale+OE,$41.35,-26000,33522,-44%,"-$1,074,998",,,,,XOMA
8,D,2020-12-17 16:30:19,2020-12-15,XOMA,Burns Thomas M.,"SVP, Finance, CFO",A - Grant,$25.00,2000,12238,+20%,"+$50,000",,,,,XOMA
9,D,2020-12-17 16:30:19,2020-12-15,XOMA,Burns Thomas M.,"SVP, Finance, CFO",M - OptEx,$4.03,15000,12238,-543%,"+$60,450",,,,,XOMA
10,D,2020-12-17 16:30:19,2020-12-15,XOMA,Burns Thomas M.,"SVP, Finance, CFO",S - Sale+OE,$41.41,-15000,12238,-55%,"-$621,086",,,,,XOMA
11,,2020-12-17 16:30:17,2020-12-15,XOMA,Hernday Natasha,Dir,A - Grant,$25.00,4000,4000,New,"+$100,000",,,,,XOMA
12,D,2020-12-15 19:12:35,2020-12-11,XOMA,Perry Matthew D,See Explanation of Responses,P - Purchase,$25.00,200000,211799,>999%,"+$5,000,000",,,,,XOMA
13,D,2020-12-15 19:09:37,2020-12-11,XOMA,Bvf Partners L P/il,"See Remarks, 10%",P - Purchase,$25.00,200000,4394042,+5%,"+$5,000,000",,,,,XOMA
14,DM,2020-11-24 16:30:17,2020-11-20,XOMA,Burns Thomas M.,"SVP, Finance, CFO",M - OptEx,$4.03,12000,10238,-681%,"+$48,360",,,,,XOMA
15,DM,2020-11-24 16:30:17,2020-11-20,XOMA,Burns Thomas M.,"SVP, Finance, CFO",S - Sale+OE,$32.69,-12000,10238,-54%,"-$392,308",,,,,XOMA
16,DM,2020-11-24 16:30:17,2020-11-20,XOMA,Neal James R,CEO,M - OptEx,$5.50,20000,25522,+362%,"+$110,000",,,,,XOMA
17,DM,2020-11-24 16:30:17,2020-11-20,XOMA,Neal James R,CEO,S - Sale+OE,$32.81,-20000,25522,-44%,"-$656,184",,,,,XOMA
18,D,2020-11-06 17:20:15,2020-11-05,XOMA,Neal James R,CEO,M - OptEx,$5.50,10000,25522,+64%,"+$55,000",,,,,XOMA
19,D,2020-11-06 17:20:15,2020-11-05,XOMA,Neal James R,CEO,S - Sale+OE,$26.02,-10000,25522,-28%,"-$260,205",,,,,XOMA
20,D,2020-11-06 17:20:14,2020-11-05,XOMA,Burns Thomas M.,"SVP, Finance, CFO",M - OptEx,$4.03,8000,10238,+357%,"+$32,240",,,,,XOMA
21,D,2020-11-06 17:20:14,2020-11-05,XOMA,Burns Thomas M.,"SVP, Finance, CFO",S - Sale+OE,$26.11,-8000,10238,-44%,"-$208,908",,,,,XOMA
22,DM,2020-09-23 19:26:48,2020-09-21,XOMA,Bvf Partners L P/il,"See Remarks, 10%",P - Purchase,$18.34,51368,2153918,+2%,"+$941,963",,,,,XOMA
23,D,2020-09-10 08:10:40,2020-09-04,XOMA,Bvf Partners L P/il,"See Remarks, 10%",P - Purchase,$18.77,7737,2131657,0%,"+$145,228",,,,,XOMA
24,DM,2020-09-01 20:37:40,2020-08-28,XOMA,Bvf Partners L P/il,"See Remarks, 10%",P - Purchase,$18.71,35621,2116028,+2%,"+$666,484",,,,,XOMA
25,DM,2020-08-25 20:10:26,2020-08-21,XOMA,Bvf Partners L P/il,"See Remarks, 10%",P - Purchase,$19.40,28175,2100572,+1%,"+$546,650",,,,,XOMA
26,DM,2020-08-20 18:56:08,2020-08-18,XOMA,Bvf Partners L P/il,10%,P - Purchase,$19.47,6163,4059342,0%,"+$120,004",,,,,XOMA
27,DM,2020-08-14 18:38:48,2020-08-12,XOMA,Bvf Partners L P/il,10%,P - Purchase,$18.46,27022,4053179,+1%,"+$498,736",,,,,XOMA
28,D,2020-04-17 17:13:11,2020-04-15,XOMA,Bvf Partners L P/il,10%,C - Converted deriv,$13.00,1252772,2091542,-37%,"$16,286,036",,,,,XOMA
29,D,2020-03-27 20:29:37,2020-03-25,XOMA,Bvf Partners L P/il,10%,P - Purchase,$17.20,8264,2773385,0%,"+$142,129",,,,,XOMA
30,,2020-03-24 16:38:25,2020-03-23,XOMA,Neal James R,CEO,P - Purchase,$14.50,1000,25522,+4%,"+$14,500",,,,,XOMA
31,,2020-03-23 16:30:13,2020-03-20,XOMA,Neal James R,CEO,P - Purchase,$16.41,1000,24522,+4%,"+$16,410",,,,,XOMA
32,D,2020-03-20 16:52:49,2020-03-18,XOMA,Bvf Partners L P/il,10%,P - Purchase,$14.52,4439,2765121,0%,"+$64,475",,,,,XOMA
33,DM,2020-03-17 21:30:42,2020-03-13,XOMA,Bvf Partners L P/il,10%,P - Purchase,$17.94,118277,2760682,+4%,"+$2,121,654",,,,,XOMA
34,D,2020-01-16 17:33:48,2019-12-23,XOMA,Neal James R,CEO,X - OptEx,$22.00,1180,23522,-5%,"$25,960",,,,,XOMA
35,D,2019-12-20 19:18:30,2019-12-19,XOMA,Bvf Partners L P/il,10%,P - Purchase,$22.00,373195,1335192,+39%,"+$8,210,290",,,,,XOMA
36,D,2019-12-20 19:18:30,2019-12-18,XOMA,Bvf Partners L P/il,10%,X - OptEx,$22.00,472268,1335192,-26%,"$10,389,896",,,,,XOMA
37,D,2019-11-08 16:30:18,2019-11-06,XOMA,Neal James R,CEO,M - OptEx,$5.50,4348,21871,+25%,"+$23,914",,,,,XOMA
38,D,2019-11-08 16:30:18,2019-11-06,XOMA,Neal James R,CEO,S - Sale+OE,$22.00,-4348,21871,-17%,"-$95,656",,,,,XOMA
39,DM,2019-09-20 19:40:41,2019-09-18,XOMA,Neal James R,CEO,M - OptEx,$5.50,15652,21871,+252%,"+$86,086",,,,,XOMA
40,DM,2019-09-20 19:40:41,2019-09-18,XOMA,Neal James R,CEO,S - Sale+OE,$21.02,-15652,21871,-42%,"-$328,928",,,,,XOMA
41,DM,2019-09-20 19:39:27,2019-09-18,XOMA,Burns Thomas M.,"SVP, Finance, CFO",M - OptEx,$4.03,8000,8945,+847%,"+$32,240",,,,,XOMA
42,DM,2019-09-20 19:39:27,2019-09-18,XOMA,Burns Thomas M.,"SVP, Finance, CFO",S - Sale+OE,$21.67,-8000,8945,-47%,"-$173,387",,,,,XOMA
43,DM,2019-05-14 21:01:58,2019-05-10,XOMA,Bvf Partners L P/il,10%,P - Purchase,$14.63,27913,1796942,+2%,"+$408,228",,,,,XOMA
44,,2019-05-14 18:38:57,2019-05-10,XOMA,Van Ness W Denman,Dir,S - Sale,$14.71,-130,9945,-1%,"-$1,912",,,,,XOMA
45,D,2018-12-21 18:24:06,2018-12-20,XOMA,Neal James R,CEO,X - OptEx,$13.00,678,23972,-3%,"$8,814",,,,,XOMA
46,D,2018-12-21 18:22:33,2018-12-20,XOMA,Van Ness W Denman,Dir,X - OptEx,$13.00,800,10075,-7%,"$10,400",,,,,XOMA
47,D,2018-12-19 21:26:05,2018-12-17,XOMA,Bvf Partners L P/il,10%,P - Purchase,$14.19,25000,1769029,+1%,"+$354,793",,,,,XOMA
48,DM,2018-12-13 18:54:37,2018-12-11,XOMA,Bvf Partners L P/il,10%,P - Purchase,$14.46,36463,1744029,+2%,"+$527,242",,,,,XOMA
49,DM,2018-12-10 19:03:03,2018-12-06,XOMA,Bvf Partners L P/il,10%,P - Purchase,$14.71,61023,1707566,+4%,"+$897,448",,,,,XOMA
50,DM,2018-12-04 19:01:17,2018-11-30,XOMA,Bvf Partners L P/il,10%,P - Purchase,$14.91,9800,1646543,+1%,"+$146,139",,,,,XOMA
51,DM,2018-11-29 17:55:24,2018-11-27,XOMA,Bvf Partners L P/il,10%,P - Purchase,$15.10,29700,1636743,+2%,"+$448,484",,,,,XOMA
52,DM,2018-11-21 17:42:54,2018-11-19,XOMA,Bvf Partners L P/il,10%,P - Purchase,$14.17,72253,1607043,+5%,"+$1,023,658",,,,,XOMA
53,DM,2018-11-19 10:21:00,2018-11-15,XOMA,Bvf Partners L P/il,10%,P - Purchase,$13.48,31990,1534790,+2%,"+$431,348",,,,,XOMA
54,D,2018-11-16 16:31:31,2018-11-15,XOMA,Van Ness W Denman,Dir,M - OptEx,$6.85,7693,9275,+486%,"+$52,699",,,,,XOMA
55,D,2018-11-16 16:31:31,2018-11-15,XOMA,Van Ness W Denman,Dir,S - Sale+OE,$12.67,-5528,9275,-37%,"-$70,040",,,,,XOMA
56,,2018-11-15 16:09:38,2018-11-13,XOMA,Neal James R,CEO,P - Purchase,$13.26,4000,23294,+21%,"+$53,056",,,,,XOMA
57,DM,2018-04-27 17:44:55,2018-04-26,XOMA,Burns Thomas M.,"SVP, Finance, CFO",M - OptEx,$5.50,11000,8945,-535%,"+$60,500",,,,,XOMA
58,DM,2018-04-27 17:44:55,2018-04-26,XOMA,Burns Thomas M.,"SVP, Finance, CFO",S - Sale+OE,$24.71,-11000,8945,-55%,"-$271,807",,,,,XOMA
59,DM,2018-04-27 17:44:41,2018-04-26,XOMA,Neal James R,CEO,M - OptEx,$5.50,24000,19294,-510%,"+$132,000",,,,,XOMA
60,DM,2018-04-27 17:44:41,2018-04-26,XOMA,Neal James R,CEO,S - Sale+OE,$24.51,-24000,19294,-55%,"-$588,285",,,,,XOMA
61,DM,2017-11-15 20:03:40,2017-11-13,XOMA,Neal James R,CEO,M - OptEx,$4.03,46296,19294,-171%,"+$186,573",,,,,XOMA
62,DM,2017-11-15 20:03:40,2017-11-13,XOMA,Neal James R,CEO,S - Sale+OE,$28.24,-46296,19294,-71%,"-$1,307,187",,,,,XOMA
63,DM,2017-11-15 20:03:17,2017-11-13,XOMA,Burns Thomas M.,"SVP, Finance, CFO",M - OptEx,$4.03,22222,8945,-167%,"+$89,555",,,,,XOMA
64,DM,2017-11-15 20:03:17,2017-11-13,XOMA,Burns Thomas M.,"SVP, Finance, CFO",S - Sale+OE,$28.69,-22222,8945,-71%,"-$637,450",,,,,XOMA
65,,2017-05-18 15:02:36,2017-05-16,XOMA,Varian John,Dir,S - Sale,$6.24,-39540,5995,-87%,"-$246,919",,,,,XOMA
66,,2017-03-23 10:45:30,2017-03-21,XOMA,Neal James R,VP Business Development,S - Sale,$5.40,-5105,18327,-22%,"-$27,569",8.0,15.0,28.0,,XOMA
67,,2017-03-23 10:31:13,2017-03-21,XOMA,Burns Thomas M.,"VP, Finance, Chief Financial",S - Sale,$5.40,-2598,8945,-23%,"-$14,030",8.0,15.0,28.0,,XOMA
68,D,2017-03-07 19:47:02,2017-03-02,XOMA,Perry Matthew D,See Explanation of Responses,A - Grant,$0.00,11799,11799,New,+$0,6.0,12.0,38.0,,XOMA
69,,2017-02-01 16:47:33,2017-02-01,XOMA,Neal James R,VP Business Development,S - Sale,$4.52,-195,21130,-1%,-$881,-2.0,-11.0,0.0,,XOMA
70,,2017-01-10 12:21:19,2017-01-09,XOMA,Neal James R,VP Business Development,S - Sale,$5.15,-125,21325,-1%,-$644,-3.0,-9.0,-19.0,,XOMA
71,,2016-12-23 18:38:45,2016-12-21,XOMA,Varian John,Dir,S - Sale,$5.75,-13549,43246,-24%,"-$77,907",-4.0,-21.0,-15.0,,XOMA
72,,2016-12-23 18:36:11,2016-12-21,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale,$5.75,-3230,10146,-24%,"-$18,573",-4.0,-21.0,-15.0,,XOMA
73,,2016-11-03 19:38:17,2016-11-01,XOMA,Neal James R,VP Business Development,S - Sale,$5.25,-150,21200,-1%,-$788,3.0,8.0,2.0,18.0,XOMA
74,,2016-10-11 17:26:05,2016-10-07,XOMA,Neal James R,VP Business Development,S - Sale,$0.45,-2500,427031,-1%,"-$1,120",-2.0,-16.0,-33.0,-21.0,XOMA
75,D,2016-08-02 19:38:38,2016-07-21,XOMA,Walbert Timothy P,Dir,A - Grant,$0.00,48246,129314,+60%,+$0,3.0,-2.0,-6.0,-65.0,XOMA
76,D,2016-08-02 19:34:00,2016-07-21,XOMA,Wyszomierski Jack L,Dir,A - Grant,$0.00,48246,129314,+60%,+$0,3.0,-2.0,-6.0,-65.0,XOMA
77,D,2016-08-02 19:27:33,2016-07-21,XOMA,Van Ness W Denman,Dir,A - Grant,$0.00,48246,142226,+51%,+$0,3.0,-2.0,-6.0,-65.0,XOMA
78,D,2016-08-02 19:22:02,2016-07-21,XOMA,Van Ness W Denman,Dir,A - Grant,$0.00,48246,142226,+51%,+$0,3.0,-2.0,-6.0,-65.0,XOMA
79,D,2016-08-02 19:14:50,2016-07-21,XOMA,Limber Joseph M,Dir,A - Grant,$0.00,48246,124219,+64%,+$0,3.0,-2.0,-6.0,-65.0,XOMA
80,D,2016-05-31 19:32:45,2016-05-28,XOMA,Wyszomierski Jack L,Dir,M - OptEx,$0.00,2800,81068,+4%,+$0,-3.0,0.0,-34.0,-52.0,XOMA
81,D,2016-05-31 19:28:34,2016-05-28,XOMA,Walbert Timothy P,Dir,M - OptEx,$0.00,2800,81068,+4%,+$0,-3.0,0.0,-34.0,-52.0,XOMA
82,D,2016-05-31 19:25:35,2016-05-28,XOMA,Van Ness W Denman,Dir,M - OptEx,$0.00,3150,93980,+3%,+$0,-3.0,0.0,-34.0,-52.0,XOMA
83,D,2016-05-31 19:21:25,2016-05-28,XOMA,Limber Joseph M,Dir,M - OptEx,$0.00,2800,75973,+4%,+$0,-3.0,0.0,-34.0,-52.0,XOMA
84,,2016-03-22 21:05:27,2016-03-22,XOMA,Burns Thomas M.,"VP, Finance, Chief Financial",S - Sale,$0.78,-19249,196559,-9%,"-$15,105",-3.0,-10.0,6.0,-33.0,XOMA
85,,2016-03-22 21:03:37,2016-03-22,XOMA,Neal James R,VP Business Development,S - Sale,$0.78,-19813,424531,-4%,"-$15,547",-3.0,-10.0,6.0,-33.0,XOMA
86,D,2016-03-22 21:01:31,2016-03-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$0.00,12141,340023,+4%,+$0,-3.0,-10.0,6.0,-33.0,XOMA
87,D,2016-03-22 21:01:31,2016-03-22,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$0.78,-24194,340023,-7%,"-$18,985",-3.0,-10.0,6.0,-33.0,XOMA
88,D,2016-03-22 20:58:52,2016-03-18,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",M - OptEx,$0.00,9500,267546,+4%,+$0,-3.0,-10.0,6.0,-33.0,XOMA
89,D,2016-03-22 20:58:52,2016-03-22,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale+OE,$0.78,-14785,267546,-5%,"-$11,602",-3.0,-10.0,6.0,-33.0,XOMA
90,D,2016-03-22 20:55:58,2016-03-18,XOMA,Varian John,CEO,M - OptEx,$0.00,36907,1135932,+3%,+$0,-3.0,-10.0,6.0,-33.0,XOMA
91,D,2016-03-22 20:55:58,2016-03-22,XOMA,Varian John,CEO,S - Sale+OE,$0.78,-81022,1135932,-7%,"-$63,578",-3.0,-10.0,6.0,-33.0,XOMA
92,,2016-02-29 18:20:41,2016-02-25,XOMA,Varian John,CEO,A - Grant,$0.00,541600,1180047,+85%,+$0,1.0,8.0,-5.0,-23.0,XOMA
93,,2016-02-29 18:13:06,2016-02-25,XOMA,Neal James R,VP Business Development,A - Grant,$0.00,248954,444344,+127%,+$0,1.0,8.0,-5.0,-23.0,XOMA
94,,2016-02-29 18:04:01,2016-02-25,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",A - Grant,$0.00,198330,352076,+129%,+$0,1.0,8.0,-5.0,-23.0,XOMA
95,,2016-02-29 17:59:39,2016-02-25,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",A - Grant,$0.00,140000,272831,+105%,+$0,1.0,8.0,-5.0,-23.0,XOMA
96,,2016-02-29 17:54:37,2016-02-25,XOMA,Burns Thomas M.,"VP, Finance, Chief Financial",A - Grant,$0.00,108560,215808,+101%,+$0,1.0,8.0,-5.0,-23.0,XOMA
97,,2016-02-03 16:46:10,2016-02-01,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale,$1.01,-8000,124110,-6%,"-$8,080",0.0,-18.0,-15.0,-32.0,XOMA
98,,2015-12-30 17:05:55,2015-12-28,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale,$1.37,-8000,132110,-6%,"-$10,937",-2.0,-9.0,-25.0,-53.0,XOMA
99,D,2015-12-15 16:37:57,2015-12-12,XOMA,Limber Joseph M,Dir,M - OptEx,$0.00,5600,73173,+8%,+$0,9.0,12.0,-20.0,-53.0,XOMA
100,,2015-11-25 18:14:47,2015-11-23,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale,$1.35,-8000,140110,-5%,"-$10,800",-1.0,2.0,1.0,-51.0,XOMA
101,,2015-10-28 17:44:07,2015-10-26,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale,$1.04,-8000,148110,-5%,"-$8,358",-9.0,43.0,6.0,-31.0,XOMA
102,D,2015-08-18 21:24:19,2015-08-14,XOMA,Varian John,CEO,D - Sale to issuer,$0.83,-35799,629726,-5%,"-$29,838",-3.0,-16.0,-3.0,-5.0,XOMA
103,D,2015-08-18 21:24:19,2015-08-14,XOMA,Varian John,CEO,M - OptEx,$0.00,94573,629726,+18%,+$0,-3.0,-16.0,-3.0,-5.0,XOMA
104,D,2015-08-18 21:20:44,2015-08-14,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",D - Sale to issuer,$0.83,-6157,156110,-4%,"-$5,132",-3.0,-16.0,-3.0,-5.0,XOMA
105,D,2015-08-18 21:20:44,2015-08-14,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",M - OptEx,$0.00,16264,156110,+12%,+$0,-3.0,-16.0,-3.0,-5.0,XOMA
106,D,2015-08-18 20:24:14,2015-08-14,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",D - Sale to issuer,$0.83,-10801,145173,-7%,"-$9,003",-3.0,-16.0,-3.0,-5.0,XOMA
107,D,2015-08-18 20:24:14,2015-08-14,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$0.00,26748,145173,+23%,+$0,-3.0,-16.0,-3.0,-5.0,XOMA
108,,2015-08-18 19:49:28,2015-08-14,XOMA,Neal James R,VP Business Development,D - Sale to issuer,$0.83,-9067,179873,-5%,"-$7,557",-3.0,-16.0,-3.0,-5.0,XOMA
109,,2015-07-23 17:35:06,2015-07-22,XOMA,Baker Bros. Advisors LP,Former 10% owner,S - Sale,$1.09,-11000000,90538,-99%,"-$12,017,500",-10.0,-21.0,-26.0,2.0,XOMA
110,D,2015-07-17 18:03:17,2015-07-15,XOMA,Varian John,CEO,M - OptEx,$1.24,10000,570952,+2%,"+$12,400",0.0,-75.0,-79.0,-75.0,XOMA
111,D,2015-07-17 18:03:17,2015-07-15,XOMA,Varian John,CEO,S - Sale+OE,$4.49,-10000,570952,-2%,"-$44,869",0.0,-75.0,-79.0,-75.0,XOMA
112,D,2015-07-17 18:02:06,2015-07-15,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$3.04,5000,129226,+4%,"+$15,200",0.0,-75.0,-79.0,-75.0,XOMA
113,D,2015-07-17 18:02:06,2015-07-15,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$4.60,-5000,129226,-4%,"-$22,992",0.0,-75.0,-79.0,-75.0,XOMA
114,DM,2015-07-10 18:57:26,2015-07-09,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$3.04,33400,129226,+35%,"+$101,536",-7.0,-1.0,-88.0,-81.0,XOMA
115,DM,2015-07-10 18:57:26,2015-07-09,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$4.55,-33400,129226,-21%,"-$152,005",-7.0,-1.0,-88.0,-81.0,XOMA
116,D,2015-06-17 15:41:41,2015-06-15,XOMA,Varian John,CEO,M - OptEx,$1.24,10000,570952,+2%,"+$12,400",-1.0,17.0,28.0,-67.0,XOMA
117,D,2015-06-17 15:41:41,2015-06-15,XOMA,Varian John,CEO,S - Sale+OE,$3.64,-10000,570952,-2%,"-$36,362",-1.0,17.0,28.0,-67.0,XOMA
118,D,2015-06-01 18:24:53,2015-05-28,XOMA,Bowes William K Jr,Dir,M - OptEx,$0.00,5600,80339,+7%,+$0,-1.0,3.0,5.0,-61.0,XOMA
119,D,2015-06-01 18:24:46,2015-05-28,XOMA,Van Ness W Denman,Dir,M - OptEx,$0.00,6300,90830,+7%,+$0,-1.0,3.0,5.0,-61.0,XOMA
120,D,2015-06-01 18:24:31,2015-05-28,XOMA,Limber Joseph M,Dir,M - OptEx,$0.00,2800,67573,+4%,+$0,-1.0,3.0,5.0,-61.0,XOMA
121,D,2015-06-01 18:24:20,2015-05-28,XOMA,Walbert Timothy P,Dir,M - OptEx,$0.00,5600,78268,+8%,+$0,-1.0,3.0,5.0,-61.0,XOMA
122,D,2015-06-01 18:24:12,2015-05-28,XOMA,Wyszomierski Jack L,Dir,M - OptEx,$0.00,5600,78268,+8%,+$0,-1.0,3.0,5.0,-61.0,XOMA
123,D,2015-06-01 18:24:03,2015-05-28,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$0.00,4666,129226,+4%,+$0,-1.0,3.0,5.0,-61.0,XOMA
124,D,2015-06-01 18:24:03,2015-05-28,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$3.60,-1788,129226,-1%,"-$6,437",-1.0,3.0,5.0,-61.0,XOMA
125,D,2015-05-22 18:53:17,2015-05-21,XOMA,Bowes William K Jr,Dir,A - Grant,$0.00,36873,74739,+97%,+$0,-2.0,3.0,25.0,-58.0,XOMA
126,D,2015-05-22 18:53:02,2015-05-21,XOMA,Limber Joseph M,Dir,A - Grant,$0.00,36873,64773,+132%,+$0,-2.0,3.0,25.0,-58.0,XOMA
127,D,2015-05-22 18:52:55,2015-05-21,XOMA,Van Ness W Denman,Dir,A - Grant,$0.00,36873,84530,+77%,+$0,-2.0,3.0,25.0,-58.0,XOMA
128,D,2015-05-22 18:52:47,2015-05-21,XOMA,Walbert Timothy P,Dir,A - Grant,$0.00,36873,72668,+103%,+$0,-2.0,3.0,25.0,-58.0,XOMA
129,D,2015-05-22 18:52:40,2015-05-21,XOMA,Wyszomierski Jack L,Dir,A - Grant,$0.00,36873,72668,+103%,+$0,-2.0,3.0,25.0,-58.0,XOMA
130,D,2015-05-19 18:08:55,2015-05-15,XOMA,Varian John,CEO,M - OptEx,$1.24,10000,570952,+2%,"+$12,400",1.0,-1.0,7.0,-60.0,XOMA
131,D,2015-05-19 18:08:55,2015-05-15,XOMA,Varian John,CEO,S - Sale+OE,$3.34,-10000,570952,-2%,"-$33,400",1.0,-1.0,7.0,-60.0,XOMA
132,D,2015-04-15 18:50:24,2015-04-15,XOMA,Varian John,CEO,M - OptEx,$1.24,10000,570952,+2%,"+$12,400",0.0,-4.0,-10.0,-74.0,XOMA
133,D,2015-04-15 18:50:24,2015-04-15,XOMA,Varian John,CEO,S - Sale+OE,$3.86,-10000,570952,-2%,"-$38,606",0.0,-4.0,-10.0,-74.0,XOMA
134,D,2015-04-07 19:20:48,2015-04-06,XOMA,Kurland Fred,"CFO, VP Finance",D - Sale to issuer,$3.61,-35275,102852,-26%,"-$127,251",4.0,9.0,-13.0,-74.0,XOMA
135,D,2015-04-07 19:20:48,2015-04-06,XOMA,Kurland Fred,"CFO, VP Finance",M - OptEx,$0.00,29938,102852,+41%,+$0,4.0,9.0,-13.0,-74.0,XOMA
136,,2015-03-23 18:35:45,2015-03-23,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale,$3.94,-32742,126348,-21%,"-$128,879",-2.0,-9.0,-8.0,-79.0,XOMA
137,D,2015-03-20 19:30:42,2015-03-18,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",D - Sale to issuer,$4.01,-8666,146003,-6%,"-$34,755",0.0,-10.0,-7.0,-76.0,XOMA
138,D,2015-03-20 19:30:42,2015-03-18,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",M - OptEx,$0.00,9500,146003,+7%,+$0,0.0,-10.0,-7.0,-76.0,XOMA
139,D,2015-03-20 19:30:35,2015-03-18,XOMA,Klein Thomas,Chief Commercial Officer,D - Sale to issuer,$4.01,-53037,190340,-22%,"-$212,705",0.0,-10.0,-7.0,-76.0,XOMA
140,D,2015-03-20 19:30:35,2015-03-18,XOMA,Klein Thomas,Chief Commercial Officer,M - OptEx,$0.00,80667,190340,+74%,+$0,0.0,-10.0,-7.0,-76.0,XOMA
141,D,2015-03-20 19:30:28,2015-03-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",D - Sale to issuer,$4.01,-20535,159090,-11%,"-$82,356",0.0,-10.0,-7.0,-76.0,XOMA
142,D,2015-03-20 19:30:28,2015-03-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$0.00,30346,159090,+24%,+$0,0.0,-10.0,-7.0,-76.0,XOMA
143,,2015-03-20 19:30:20,2015-03-18,XOMA,Neal James R,VP Business Development,D - Sale to issuer,$4.01,-9019,188940,-5%,"-$36,171",0.0,-10.0,-7.0,-76.0,XOMA
144,D,2015-03-20 19:30:11,2015-03-18,XOMA,Kurland Fred,"CFO, VP Finance",D - Sale to issuer,$4.01,-9163,108189,-8%,"-$36,748",0.0,-10.0,-7.0,-76.0,XOMA
145,D,2015-03-20 19:30:11,2015-03-18,XOMA,Kurland Fred,"CFO, VP Finance",M - OptEx,$0.00,10875,108189,+11%,+$0,0.0,-10.0,-7.0,-76.0,XOMA
146,D,2015-03-20 19:30:03,2015-03-18,XOMA,Varian John,CEO,D - Sale to issuer,$4.01,-44877,570952,-7%,"-$179,979",0.0,-10.0,-7.0,-76.0,XOMA
147,D,2015-03-20 19:30:03,2015-03-18,XOMA,Varian John,CEO,M - OptEx,$0.00,36907,570952,+7%,+$0,0.0,-10.0,-7.0,-76.0,XOMA
148,D,2015-03-17 18:52:27,2015-03-16,XOMA,Varian John,CEO,M - OptEx,$1.24,10000,578922,+2%,"+$12,400",2.0,2.0,-2.0,-83.0,XOMA
149,D,2015-03-17 18:52:27,2015-03-16,XOMA,Varian John,CEO,S - Sale+OE,$3.72,-10000,578922,-2%,"-$37,223",2.0,2.0,-2.0,-83.0,XOMA
150,D,2015-03-02 19:42:40,2015-02-26,XOMA,Varian John,CEO,A - Grant,$0.00,193200,578922,+50%,+$0,0.0,-5.0,0.0,-79.0,XOMA
151,D,2015-03-02 19:42:29,2015-02-26,XOMA,Klein Thomas,Chief Commercial Officer,A - Grant,$0.00,64900,162710,+66%,+$0,0.0,-5.0,0.0,-79.0,XOMA
152,,2015-03-02 19:42:21,2015-02-26,XOMA,Kurland Fred,"CFO, VP Finance",A - Grant,$0.00,10000,106477,+10%,+$0,0.0,-5.0,0.0,-79.0,XOMA
153,D,2015-03-02 19:42:14,2015-02-26,XOMA,Neal James R,VP Business Development,A - Grant,$0.00,52500,197959,+36%,+$0,0.0,-5.0,0.0,-79.0,XOMA
154,D,2015-03-02 19:42:06,2015-02-26,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",A - Grant,$0.00,38940,145169,+37%,+$0,0.0,-5.0,0.0,-79.0,XOMA
155,D,2015-03-02 19:41:57,2015-02-26,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",A - Grant,$0.00,64900,149279,+77%,+$0,0.0,-5.0,0.0,-79.0,XOMA
156,D,2015-02-19 18:09:10,2015-02-17,XOMA,Varian John,CEO,M - OptEx,$1.24,10000,385722,+3%,"+$12,400",4.0,2.0,7.0,-83.0,XOMA
157,D,2015-02-19 18:09:10,2015-02-17,XOMA,Varian John,CEO,S - Sale+OE,$3.52,-10000,385722,-3%,"-$35,192",4.0,2.0,7.0,-83.0,XOMA
158,,2015-02-04 17:36:41,2015-02-03,XOMA,Kurland Fred,"CFO, VP Finance",G - Gift,$0.00,-16000,93476,-15%,-$0,2.0,-2.0,9.0,-73.0,XOMA
159,,2015-02-03 13:38:08,2015-02-02,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale,$3.52,-5000,103228,-5%,"-$17,622",-1.0,-6.0,4.0,-78.0,XOMA
160,D,2015-01-16 17:22:41,2015-01-15,XOMA,Varian John,CEO,M - OptEx,$1.24,10000,382721,+3%,"+$12,400",3.0,-1.0,2.0,29.0,XOMA
161,D,2015-01-16 17:22:41,2015-01-15,XOMA,Varian John,CEO,S - Sale+OE,$3.46,-10000,382721,-3%,"-$34,582",3.0,-1.0,2.0,29.0,XOMA
162,M,2015-01-06 20:31:00,2015-01-02,XOMA,Baker Bros. Advisors LP,"Dir, 10%",S - Sale,$3.81,-2215400,345074,-87%,"-$8,437,818",4.0,5.0,-4.0,10.0,XOMA
163,,2015-01-05 17:32:12,2015-01-02,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale,$3.55,-5000,108228,-4%,"-$17,756",-9.0,-6.0,-10.0,0.0,XOMA
164,M,2014-12-30 17:40:27,2014-12-26,XOMA,Baker Bros. Advisors LP,"Dir, 10%",S - Sale,$3.67,-744000,392617,-65%,"-$2,729,139",0.0,-2.0,2.0,8.0,XOMA
165,M,2014-12-19 17:13:18,2014-12-17,XOMA,Baker Bros. Advisors LP,"Dir, 10%",S - Sale,$4.26,-1605100,408603,-80%,"-$6,837,395",-1.0,-7.0,-14.0,6.0,XOMA
166,M,2014-12-16 17:29:10,2014-12-12,XOMA,Baker Bros. Advisors LP,"Dir, 10%",S - Sale,$4.46,-1033800,443096,-70%,"-$4,610,337",4.0,-4.0,-15.0,-12.0,XOMA
167,D,2014-12-16 13:01:22,2014-12-15,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$3.04,1600,77331,+2%,"+$4,864",-3.0,-8.0,-19.0,-15.0,XOMA
168,D,2014-12-16 13:01:22,2014-12-15,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$4.63,-1600,77331,-2%,"-$7,401",-3.0,-8.0,-19.0,-15.0,XOMA
169,D,2014-12-16 13:01:14,2014-12-15,XOMA,Varian John,CEO,M - OptEx,$1.24,10000,382721,+3%,"+$12,400",-3.0,-8.0,-19.0,-15.0,XOMA
170,D,2014-12-16 13:01:14,2014-12-15,XOMA,Varian John,CEO,S - Sale+OE,$4.49,-10000,382721,-3%,"-$44,929",-3.0,-8.0,-19.0,-15.0,XOMA
171,D,2014-12-12 18:16:52,2014-12-12,XOMA,Limber Joseph M,Dir,M - OptEx,$0.00,5600,27900,+25%,+$0,-8.0,-9.0,-22.0,-21.0,XOMA
172,,2014-12-10 17:50:54,2014-12-09,XOMA,Baker Bros. Advisors LP,"Dir, 10%",S - Sale,$4.62,-392353,465335,-46%,"-$1,811,062",-2.0,-13.0,-23.0,-20.0,XOMA
173,M,2014-12-04 18:05:57,2014-12-02,XOMA,Baker Bros. Advisors LP,"Dir, 10%",S - Sale,$4.79,-2372206,473764,-83%,"-$11,357,289",5.0,7.0,-12.0,-18.0,XOMA
174,,2014-12-01 17:29:06,2014-11-26,XOMA,Neal James R,VP Business Development,S - Sale,$5.67,-1678,139230,-1%,"-$9,514",-9.0,-16.0,-35.0,-37.0,XOMA
175,,2014-12-01 17:28:57,2014-12-01,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale,$5.51,-5000,113228,-4%,"-$27,569",-9.0,-16.0,-35.0,-37.0,XOMA
176,,2014-11-24 18:25:42,2014-11-24,XOMA,Neal James R,VP Business Development,S - Sale,$5.03,-1032,140908,-1%,"-$5,193",5.0,7.0,-37.0,-42.0,XOMA
177,D,2014-11-21 14:46:38,2014-11-20,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$3.04,5000,77331,+7%,"+$15,200",1.0,25.0,-13.0,-26.0,XOMA
178,D,2014-11-21 14:46:38,2014-11-20,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$4.55,-5000,77331,-6%,"-$22,750",1.0,25.0,-13.0,-26.0,XOMA
179,D,2014-11-17 17:46:16,2014-11-13,XOMA,Bowes William K Jr,Dir,M - OptEx,$0.00,4498,37866,+13%,+$0,2.0,16.0,4.0,-15.0,XOMA
180,D,2014-11-17 17:46:06,2014-11-13,XOMA,Van Ness W Denman,Dir,M - OptEx,$0.00,6875,47657,+17%,+$0,2.0,16.0,4.0,-15.0,XOMA
181,D,2014-11-17 17:45:53,2014-11-13,XOMA,Walbert Timothy P,Dir,M - OptEx,$0.00,4498,35795,+14%,+$0,2.0,16.0,4.0,-15.0,XOMA
182,D,2014-11-17 17:45:39,2014-11-13,XOMA,Wyszomierski Jack L,Dir,M - OptEx,$0.00,4498,35795,+14%,+$0,2.0,16.0,4.0,-15.0,XOMA
183,D,2014-11-17 17:45:24,2014-11-13,XOMA,Kurland Fred,"CFO, VP Finance",M - OptEx,$0.00,22596,109476,+26%,+$0,2.0,16.0,4.0,-15.0,XOMA
184,D,2014-11-17 17:45:24,2014-11-13,XOMA,Kurland Fred,"CFO, VP Finance",S - Sale+OE,$3.89,-8773,109476,-7%,"-$34,148",2.0,16.0,4.0,-15.0,XOMA
185,D,2014-11-17 17:45:01,2014-11-13,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",M - OptEx,$0.00,22652,118228,+24%,+$0,2.0,16.0,4.0,-15.0,XOMA
186,D,2014-11-17 17:45:01,2014-11-13,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale+OE,$3.89,-8245,118228,-7%,"-$32,093",2.0,16.0,4.0,-15.0,XOMA
187,D,2014-11-17 17:44:21,2014-11-13,XOMA,Varian John,CEO,M - OptEx,$0.00,100664,382721,+36%,+$0,2.0,16.0,4.0,-15.0,XOMA
188,DM,2014-11-17 17:44:21,2013-11-13,XOMA,Varian John,CEO,S - Sale+OE,$3.89,-58844,382721,-13%,"-$229,044",2.0,16.0,4.0,-15.0,XOMA
189,,2014-11-17 17:44:08,2014-11-13,XOMA,Neal James R,VP Business Development,S - Sale,$3.89,-4387,141940,-3%,"-$17,076",2.0,16.0,4.0,-15.0,XOMA
190,,2014-11-03 19:37:42,2014-11-03,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale,$4.33,-5000,103821,-5%,"-$21,660",-3.0,-11.0,19.0,-27.0,XOMA
191,D,2014-10-29 15:11:39,2014-10-28,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$3.04,5000,77331,+7%,"+$15,200",-3.0,-9.0,24.0,-35.0,XOMA
192,D,2014-10-29 15:11:39,2014-10-28,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$4.57,-5000,77331,-6%,"-$22,829",-3.0,-9.0,24.0,-35.0,XOMA
193,D,2014-10-15 18:20:29,2014-10-15,XOMA,Varian John,CEO,M - OptEx,$1.24,10000,340901,+3%,"+$12,400",3.0,9.0,4.0,-3.0,XOMA
194,D,2014-10-15 18:20:29,2014-10-15,XOMA,Varian John,CEO,S - Sale+OE,$3.87,-10000,340901,-3%,"-$38,690",3.0,9.0,4.0,-3.0,XOMA
195,,2014-10-01 18:15:47,2014-10-01,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale,$4.09,-5000,108821,-4%,"-$20,447",0.0,-5.0,8.0,-13.0,XOMA
196,D,2014-09-16 18:26:13,2014-09-12,XOMA,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$0.00,16500,524349,+3%,+$0,1.0,-3.0,-17.0,-14.0,XOMA
197,D,2014-09-16 16:47:42,2014-09-12,XOMA,Wyszomierski Jack L,Dir,A - Grant,$0.00,5500,31297,+21%,+$0,1.0,-3.0,-17.0,-14.0,XOMA
198,D,2014-09-16 16:44:45,2014-09-12,XOMA,Walbert Timothy P,Dir,A - Grant,$0.00,5500,31297,+21%,+$0,1.0,-3.0,-17.0,-14.0,XOMA
199,D,2014-09-16 16:42:12,2014-09-12,XOMA,Van Ness W Denman,Dir,A - Grant,$0.00,5500,40782,+16%,+$0,1.0,-3.0,-17.0,-14.0,XOMA
200,D,2014-09-16 16:41:59,2014-09-12,XOMA,Limber Joseph M,Dir,A - Grant,$0.00,5500,22300,+33%,+$0,1.0,-3.0,-17.0,-14.0,XOMA
201,D,2014-09-16 16:41:38,2014-09-12,XOMA,Bowes William K Jr,Dir,A - Grant,$0.00,5500,33368,+20%,+$0,1.0,-3.0,-17.0,-14.0,XOMA
202,D,2014-09-16 16:41:26,2014-09-15,XOMA,Varian John,CEO,M - OptEx,$1.24,10000,340901,+3%,"+$12,400",1.0,-3.0,-17.0,-14.0,XOMA
203,D,2014-09-16 16:41:26,2014-09-15,XOMA,Varian John,CEO,S - Sale+OE,$4.56,-10000,340901,-3%,"-$45,577",1.0,-3.0,-17.0,-14.0,XOMA
204,D,2014-09-16 16:41:17,2014-09-15,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$3.04,5000,77331,+7%,"+$15,200",1.0,-3.0,-17.0,-14.0,XOMA
205,D,2014-09-16 16:41:17,2014-09-15,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$4.59,-5000,77331,-6%,"-$22,939",1.0,-3.0,-17.0,-14.0,XOMA
206,D,2014-09-08 17:17:32,2014-09-04,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$3.04,10000,77331,+15%,"+$30,400",-4.0,4.0,-12.0,-18.0,XOMA
207,D,2014-09-08 17:17:32,2014-09-04,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$4.56,-10000,77331,-11%,"-$45,640",-4.0,4.0,-12.0,-18.0,XOMA
208,,2014-09-03 14:42:35,2014-09-02,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale,$4.31,-5000,113821,-4%,"-$21,553",2.0,2.0,-5.0,-15.0,XOMA
209,D,2014-08-19 12:47:27,2014-08-14,XOMA,Kurland Fred,"CFO, VP Finance",M - OptEx,$0.00,19064,95653,+25%,+$0,0.0,-4.0,6.0,-16.0,XOMA
210,D,2014-08-19 12:47:27,2014-08-15,XOMA,Kurland Fred,"CFO, VP Finance",S - Sale+OE,$4.31,-10401,95653,-10%,"-$44,780",0.0,-4.0,6.0,-16.0,XOMA
211,D,2014-08-19 12:47:19,2014-08-14,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$0.00,26748,77331,+53%,+$0,0.0,-4.0,6.0,-16.0,XOMA
212,DM,2014-08-19 12:47:19,2014-08-15,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$4.34,-26748,77331,-26%,"-$116,093",0.0,-4.0,6.0,-16.0,XOMA
213,,2014-08-18 18:21:38,2014-08-15,XOMA,Neal James R,VP Business Development,S - Sale,$4.61,-6584,146327,-4%,"-$30,322",0.0,-3.0,5.0,-19.0,XOMA
214,D,2014-08-18 18:21:25,2014-08-14,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",M - OptEx,$0.00,16264,118821,+16%,+$0,0.0,-3.0,5.0,-19.0,XOMA
215,D,2014-08-18 18:21:25,2014-08-15,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale+OE,$4.31,-5871,118821,-5%,"-$25,277",0.0,-3.0,5.0,-19.0,XOMA
216,DM,2014-08-18 18:21:17,2014-08-14,XOMA,Varian John,CEO,M - OptEx,$0.12,104574,340901,+44%,"+$12,400",0.0,-3.0,5.0,-19.0,XOMA
217,D,2014-08-18 18:21:17,2014-08-15,XOMA,Varian John,CEO,S - Sale+OE,$4.30,-64823,340901,-16%,"-$279,035",0.0,-3.0,5.0,-19.0,XOMA
218,,2014-08-04 18:53:07,2014-08-01,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale,$3.83,-5000,108428,-4%,"-$19,162",-3.0,0.0,7.0,-13.0,XOMA
219,D,2014-07-16 17:18:43,2014-07-15,XOMA,Varian John,CEO,M - OptEx,$1.24,10000,301150,+3%,"+$12,400",-5.0,3.0,6.0,-7.0,XOMA
220,D,2014-07-16 17:18:43,2014-07-15,XOMA,Varian John,CEO,S - Sale+OE,$4.03,-10000,301150,-3%,"-$40,285",-5.0,3.0,6.0,-7.0,XOMA
221,,2014-07-02 16:28:30,2014-07-01,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale,$4.68,-5000,113428,-4%,"-$23,411",-2.0,-12.0,-20.0,-26.0,XOMA
222,D,2014-06-18 17:14:11,2014-06-16,XOMA,Varian John,CEO,M - OptEx,$1.24,10000,301150,+3%,"+$12,400",0.0,-4.0,-24.0,-12.0,XOMA
223,D,2014-06-18 17:14:11,2014-06-16,XOMA,Varian John,CEO,S - Sale+OE,$4.54,-10000,301150,-3%,"-$45,410",0.0,-4.0,-24.0,-12.0,XOMA
224,,2014-06-18 17:14:03,2014-06-16,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale,$4.54,-11580,77331,-13%,"-$52,595",0.0,-4.0,-24.0,-12.0,XOMA
225,D,2014-05-29 17:49:49,2014-05-28,XOMA,Bowes William K Jr,Dir,M - OptEx,$0.00,5600,27868,+25%,+$0,-2.0,-3.0,9.0,25.0,XOMA
226,D,2014-05-29 17:49:36,2014-05-28,XOMA,Van Ness W Denman,Dir,M - OptEx,$0.00,6300,35282,+22%,+$0,-2.0,-3.0,9.0,25.0,XOMA
227,D,2014-05-29 17:49:25,2014-05-28,XOMA,Limber Joseph M,Dir,M - OptEx,$0.00,2800,16800,+20%,+$0,-2.0,-3.0,9.0,25.0,XOMA
228,D,2014-05-29 17:49:08,2014-05-28,XOMA,Walbert Timothy P,Dir,M - OptEx,$0.00,5600,25797,+28%,+$0,-2.0,-3.0,9.0,25.0,XOMA
229,D,2014-05-29 17:48:55,2014-05-28,XOMA,Wyszomierski Jack L,Dir,M - OptEx,$0.00,5600,25797,+28%,+$0,-2.0,-3.0,9.0,25.0,XOMA
230,D,2014-05-29 17:48:44,2014-05-28,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$0.00,4667,88911,+6%,+$0,-2.0,-3.0,9.0,25.0,XOMA
231,D,2014-05-29 17:48:44,2014-05-28,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$4.22,-1785,88911,-2%,"-$7,533",-2.0,-3.0,9.0,25.0,XOMA
232,D,2014-05-27 17:40:31,2014-05-22,XOMA,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$0.00,25200,518849,+5%,+$0,-1.0,-3.0,12.0,9.0,XOMA
233,D,2014-05-27 15:36:12,2014-05-22,XOMA,Limber Joseph M,Dir,A - Grant,$0.00,8400,14000,+150%,+$0,3.0,0.0,15.0,12.0,XOMA
234,D,2014-05-27 15:36:05,2014-05-22,XOMA,Walbert Timothy P,Dir,A - Grant,$0.00,8400,20197,+71%,+$0,3.0,0.0,15.0,12.0,XOMA
235,D,2014-05-27 15:35:02,2014-05-22,XOMA,Bowes William K Jr,Dir,A - Grant,$0.00,8400,22268,+61%,+$0,3.0,0.0,15.0,12.0,XOMA
236,D,2014-05-27 15:34:55,2014-05-22,XOMA,Van Ness W Denman,Dir,A - Grant,$0.00,9450,28982,+48%,+$0,3.0,0.0,15.0,12.0,XOMA
237,D,2014-05-27 15:34:47,2014-05-22,XOMA,Wyszomierski Jack L,Dir,A - Grant,$0.00,8400,20197,+71%,+$0,3.0,0.0,15.0,12.0,XOMA
238,D,2014-05-15 17:49:31,2014-05-15,XOMA,Varian John,CEO,M - OptEx,$1.24,10000,301150,+3%,"+$12,400",1.0,4.0,23.0,12.0,XOMA
239,D,2014-05-15 17:49:31,2014-05-15,XOMA,Varian John,CEO,S - Sale+OE,$3.55,-10000,301150,-3%,"-$35,515",1.0,4.0,23.0,12.0,XOMA
240,,2014-05-15 15:16:33,2014-05-13,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale,$3.84,-10000,86029,-10%,"-$38,404",-3.0,1.0,20.0,9.0,XOMA
241,D,2014-04-17 16:28:31,2014-04-15,XOMA,Varian John,CEO,M - OptEx,$1.24,10000,301150,+3%,"+$12,400",3.0,0.0,-13.0,-6.0,XOMA
242,D,2014-04-17 16:28:31,2014-04-15,XOMA,Varian John,CEO,S - Sale+OE,$4.06,-10000,301150,-3%,"-$40,645",3.0,0.0,-13.0,-6.0,XOMA
243,D,2014-03-20 15:39:19,2014-03-18,XOMA,Kurland Fred,"CFO, VP Finance",M - OptEx,$0.00,10875,86990,+14%,+$0,-1.0,-20.0,-33.0,-27.0,XOMA
244,D,2014-03-20 15:39:19,2014-03-18,XOMA,Kurland Fred,"CFO, VP Finance",S - Sale+OE,$6.32,-5915,86990,-6%,"-$37,359",-1.0,-20.0,-33.0,-27.0,XOMA
245,D,2014-03-20 15:39:11,2014-03-18,XOMA,Varian John,CEO,M - OptEx,$0.00,36907,301150,+14%,+$0,-1.0,-20.0,-33.0,-27.0,XOMA
246,D,2014-03-20 15:39:11,2014-03-18,XOMA,Varian John,CEO,S - Sale+OE,$6.32,-21329,301150,-7%,"-$134,714",-1.0,-20.0,-33.0,-27.0,XOMA
247,,2014-03-20 15:39:01,2014-03-18,XOMA,Neal James R,VP Business Development,S - Sale,$6.32,-2671,152911,-2%,"-$16,870",-1.0,-20.0,-33.0,-27.0,XOMA
248,D,2014-03-20 15:38:50,2014-03-18,XOMA,Klein Thomas,Chief Commercial Officer,M - OptEx,$0.00,80667,94809,+570%,+$0,-1.0,-20.0,-33.0,-27.0,XOMA
249,D,2014-03-20 15:38:50,2014-03-18,XOMA,Klein Thomas,Chief Commercial Officer,S - Sale+OE,$6.32,-30965,94809,-25%,"-$195,575",-1.0,-20.0,-33.0,-27.0,XOMA
250,D,2014-03-20 15:38:41,2014-03-18,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",M - OptEx,$0.00,9500,118428,+9%,+$0,-1.0,-20.0,-33.0,-27.0,XOMA
251,D,2014-03-20 15:38:41,2014-03-18,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale+OE,$6.32,-3419,118428,-3%,"-$21,594",-1.0,-20.0,-33.0,-27.0,XOMA
252,D,2014-03-20 15:38:32,2014-03-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$0.50,36347,96029,+61%,"+$18,240",-1.0,-20.0,-33.0,-27.0,XOMA
253,D,2014-03-20 15:38:32,2014-03-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$6.31,-17649,96029,-16%,"-$111,423",-1.0,-20.0,-33.0,-27.0,XOMA
254,D,2014-03-18 13:42:48,2014-03-17,XOMA,Varian John,CEO,M - OptEx,$1.24,10000,285572,+4%,"+$12,400",8.0,-9.0,-29.0,-24.0,XOMA
255,D,2014-03-18 13:42:48,2014-03-17,XOMA,Varian John,CEO,S - Sale+OE,$6.03,-10000,285572,-3%,"-$60,292",8.0,-9.0,-29.0,-24.0,XOMA
256,D,2014-03-11 16:51:15,2014-03-10,XOMA,Limber Joseph M,Dir,M - OptEx,$0.00,5600,5600,New,+$0,3.0,1.0,-18.0,-20.0,XOMA
257,D,2014-03-03 19:12:16,2014-02-27,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",A - Grant,$0.00,43448,112347,+63%,+$0,6.0,-31.0,-45.0,-55.0,XOMA
258,D,2014-03-03 19:12:01,2014-02-27,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",A - Grant,$0.00,68793,77331,+806%,+$0,6.0,-31.0,-45.0,-55.0,XOMA
259,D,2014-03-03 19:11:50,2014-02-27,XOMA,Kurland Fred,"CFO, VP Finance",A - Grant,$0.00,43448,82030,+113%,+$0,6.0,-31.0,-45.0,-55.0,XOMA
260,D,2014-03-03 19:11:38,2014-02-27,XOMA,Klein Thomas,Chief Commercial Officer,A - Grant,$0.00,43448,45107,>999%,+$0,6.0,-31.0,-45.0,-55.0,XOMA
261,D,2014-03-03 19:11:27,2014-02-27,XOMA,Varian John,CEO,A - Grant,$0.00,121296,285572,+74%,+$0,6.0,-31.0,-45.0,-55.0,XOMA
262,D,2014-02-19 16:36:19,2014-02-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$3.04,6000,8538,+236%,"+$18,240",5.0,27.0,-13.0,-39.0,XOMA
263,D,2014-02-19 16:36:19,2014-02-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$7.55,-6000,8538,-41%,"-$45,272",5.0,27.0,-13.0,-39.0,XOMA
264,D,2014-02-19 16:36:10,2014-02-18,XOMA,Varian John,CEO,M - OptEx,$1.24,10000,164276,+6%,"+$12,400",5.0,27.0,-13.0,-39.0,XOMA
265,D,2014-02-19 16:36:10,2014-02-18,XOMA,Varian John,CEO,S - Sale+OE,$7.55,-10000,164276,-6%,"-$75,478",5.0,27.0,-13.0,-39.0,XOMA
266,,2014-02-10 19:50:17,2014-02-07,XOMA,Kurland Fred,"CFO, VP Finance",G - Gift,$0.00,-7639,36842,-17%,-$0,-2.0,-5.0,-25.0,-50.0,XOMA
267,D,2014-01-23 17:25:00,2014-01-21,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$3.04,5694,7650,+291%,"+$17,310",-10.0,-8.0,2.0,-51.0,XOMA
268,D,2014-01-23 17:25:00,2014-01-21,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$8.27,-6000,7650,-44%,"-$49,608",-10.0,-8.0,2.0,-51.0,XOMA
269,D,2014-01-17 12:19:11,2014-01-15,XOMA,Varian John,CEO,M - OptEx,$1.24,10000,162536,+7%,"+$12,400",-2.0,-10.0,-11.0,-54.0,XOMA
270,D,2014-01-17 12:19:11,2014-01-15,XOMA,Varian John,CEO,S - Sale+OE,$8.28,-10000,162536,-6%,"-$82,791",-2.0,-10.0,-11.0,-54.0,XOMA
271,D,2014-01-10 15:00:46,2014-01-09,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",M - OptEx,$1.69,20000,67159,+42%,"+$33,800",2.0,3.0,-6.0,-48.0,XOMA
272,D,2014-01-10 15:00:46,2014-01-09,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale+OE,$8.00,-20000,67159,-23%,"-$160,042",2.0,3.0,-6.0,-48.0,XOMA
273,D,2013-12-18 18:54:06,2013-12-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$3.04,6000,7956,+307%,"+$18,240",8.0,23.0,44.0,-17.0,XOMA
274,D,2013-12-18 18:54:06,2013-12-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$5.67,-6000,7956,-43%,"-$33,992",8.0,23.0,44.0,-17.0,XOMA
275,D,2013-12-18 16:41:53,2013-12-16,XOMA,Varian John,CEO,M - OptEx,$1.24,10000,162536,+7%,"+$12,400",8.0,23.0,44.0,-17.0,XOMA
276,D,2013-12-18 16:41:53,2013-12-16,XOMA,Varian John,CEO,S - Sale+OE,$5.44,-10000,162536,-6%,"-$54,372",8.0,23.0,44.0,-17.0,XOMA
277,D,2013-12-03 16:22:32,2013-12-02,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",M - OptEx,$1.69,20000,67159,+42%,"+$33,800",4.0,1.0,18.0,-31.0,XOMA
278,D,2013-12-03 16:22:32,2013-12-02,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale+OE,$6.00,-20000,67159,-23%,"-$120,002",4.0,1.0,18.0,-31.0,XOMA
279,D,2013-12-02 13:19:40,2013-11-27,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$3.04,4696,7956,+144%,"+$14,276",22.0,26.0,41.0,-17.0,XOMA
280,D,2013-12-02 13:19:40,2013-11-27,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$4.54,-4696,7956,-37%,"-$21,320",22.0,26.0,41.0,-17.0,XOMA
281,D,2013-11-19 15:20:30,2013-11-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$2.36,1304,7956,+20%,"+$3,077",-2.0,5.0,49.0,-4.0,XOMA
282,D,2013-11-19 15:20:30,2013-11-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$4.08,-1304,7956,-14%,"-$5,317",-2.0,5.0,49.0,-4.0,XOMA
283,DM,2013-11-15 19:05:17,2013-11-13,XOMA,Varian John,CEO,M - OptEx,$0.11,110665,162536,+213%,"+$12,400",-6.0,-2.0,33.0,-10.0,XOMA
284,DM,2013-11-15 19:05:17,2013-11-13,XOMA,Varian John,CEO,S - Sale+OE,$3.95,-64932,162536,-29%,"-$256,267",-6.0,-2.0,33.0,-10.0,XOMA
285,D,2013-11-15 19:03:43,2013-11-13,XOMA,Wyszomierski Jack L,Dir,M - OptEx,$0.00,4498,11797,+62%,+$0,-6.0,-2.0,33.0,-10.0,XOMA
286,D,2013-11-15 19:01:46,2013-11-13,XOMA,Bowes William K Jr,Dir,M - OptEx,$0.00,4498,13868,+48%,+$0,-6.0,-2.0,33.0,-10.0,XOMA
287,D,2013-11-15 18:56:44,2013-11-13,XOMA,Walbert Timothy P,Dir,M - OptEx,$0.00,4498,11797,+62%,+$0,-6.0,-2.0,33.0,-10.0,XOMA
288,D,2013-11-15 18:54:26,2013-11-13,XOMA,Van Ness W Denman,Dir,M - OptEx,$0.00,6876,19532,+54%,+$0,-6.0,-2.0,33.0,-10.0,XOMA
289,D,2013-11-15 18:51:27,2013-11-13,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",M - OptEx,$0.00,22652,67159,+51%,+$0,-6.0,-2.0,33.0,-10.0,XOMA
290,D,2013-11-15 18:51:27,2013-11-13,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale+OE,$3.91,-8346,67159,-11%,"-$32,660",-6.0,-2.0,33.0,-10.0,XOMA
291,D,2013-11-15 18:48:09,2013-11-13,XOMA,Kurland Fred,"CFO, VP Finance",M - OptEx,$0.00,22596,44481,+103%,+$0,-6.0,-2.0,33.0,-10.0,XOMA
292,D,2013-11-15 18:48:09,2013-11-13,XOMA,Kurland Fred,"CFO, VP Finance",S - Sale+OE,$3.91,-12331,44481,-22%,"-$48,244",-6.0,-2.0,33.0,-10.0,XOMA
293,A,2013-11-01 17:33:24,2013-10-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale,$4.71,-5254,3534,-60%,"-$24,725",2.0,-4.0,36.0,10.0,XOMA
294,D,2013-10-21 16:54:06,2013-10-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$2.36,746,13210,+6%,"+$1,761",2.0,4.0,-13.0,-2.0,XOMA
295,D,2013-10-21 16:54:06,2013-10-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$4.71,-746,13210,-5%,"-$3,511",2.0,4.0,-13.0,-2.0,XOMA
296,D,2013-10-16 16:44:06,2013-10-15,XOMA,Varian John,"Dir, CEO",M - OptEx,$1.24,10000,116803,+9%,"+$12,400",4.0,-1.0,-13.0,-7.0,XOMA
297,D,2013-10-16 16:44:06,2013-10-15,XOMA,Varian John,"Dir, CEO",S - Sale+OE,$4.60,-10000,116803,-8%,"-$45,950",4.0,-1.0,-13.0,-7.0,XOMA
298,,2013-09-19 17:50:04,2013-09-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale,$4.53,-6000,12751,-32%,"-$27,187",0.0,-4.0,5.0,36.0,XOMA
299,D,2013-09-17 17:48:19,2013-09-16,XOMA,Varian John,"Dir, CEO",M - OptEx,$1.24,10000,116803,+9%,"+$12,400",-1.0,-4.0,-2.0,39.0,XOMA
300,D,2013-09-17 17:48:19,2013-09-16,XOMA,Varian John,"Dir, CEO",S - Sale+OE,$4.59,-10000,116803,-8%,"-$45,862",-1.0,-4.0,-2.0,39.0,XOMA
301,A,2013-08-21 19:54:39,2013-08-19,XOMA,Baker Bros. Advisors LP,"Dir, 10%",P - Purchase,$3.62,2757791,510449,-123%,"+$9,983,203",12.0,7.0,14.0,88.0,XOMA
302,,2013-08-21 17:07:54,2013-08-19,XOMA,Baker Bros. Advisors LP,"Dir, 10%",A - Grant,$3.62,2757791,510449,-123%,"+$9,983,203",12.0,7.0,14.0,88.0,XOMA
303,,2013-08-19 18:37:19,2013-08-19,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale,$3.74,-6000,18751,-24%,"-$22,419",12.0,20.0,26.0,98.0,XOMA
304,DM,2013-08-16 19:57:27,2013-08-14,XOMA,Varian John,"Dir, CEO",M - OptEx,$0.12,104574,116803,+855%,"+$12,400",-7.0,15.0,17.0,87.0,XOMA
305,DM,2013-08-16 19:57:27,2013-08-14,XOMA,Varian John,"Dir, CEO",S - Sale+OE,$3.87,-61647,116803,-35%,"-$238,631",-7.0,15.0,17.0,87.0,XOMA
306,D,2013-08-16 19:49:22,2013-08-14,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$0.00,26748,24751,-1339%,+$0,-7.0,15.0,17.0,87.0,XOMA
307,D,2013-08-16 19:49:22,2013-08-14,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$3.86,-10520,24751,-30%,"-$40,621",-7.0,15.0,17.0,87.0,XOMA
308,D,2013-08-16 19:42:11,2013-08-14,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",M - OptEx,$0.00,16265,52853,+44%,+$0,-7.0,15.0,17.0,87.0,XOMA
309,D,2013-08-16 19:42:11,2013-08-14,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale+OE,$3.86,-6002,52853,-10%,"-$23,175",-7.0,15.0,17.0,87.0,XOMA
310,D,2013-08-16 19:34:46,2013-08-15,XOMA,Kurland Fred,"CFO, VP Finance",G - Gift,$0.00,-13231,34216,-28%,-$0,-7.0,15.0,17.0,87.0,XOMA
311,D,2013-08-16 19:34:46,2013-08-14,XOMA,Kurland Fred,"CFO, VP Finance",M - OptEx,$0.00,19064,34216,+126%,+$0,-7.0,15.0,17.0,87.0,XOMA
312,D,2013-08-16 19:34:46,2013-08-14,XOMA,Kurland Fred,"CFO, VP Finance",S - Sale+OE,$3.86,-7498,34216,-18%,"-$28,951",-7.0,15.0,17.0,87.0,XOMA
313,D,2013-07-19 14:59:23,2013-07-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$2.73,6000,8523,+238%,"+$16,371",3.0,11.0,-17.0,78.0,XOMA
314,D,2013-07-19 14:59:23,2013-07-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$4.71,-6000,8523,-41%,"-$28,233",3.0,11.0,-17.0,78.0,XOMA
315,D,2013-07-17 15:49:01,2013-07-15,XOMA,Varian John,"Dir, CEO",M - OptEx,$1.24,10000,73876,+16%,"+$12,400",-1.0,8.0,-15.0,77.0,XOMA
316,D,2013-07-17 15:49:01,2013-07-15,XOMA,Varian John,"Dir, CEO",S - Sale+OE,$4.81,-10000,73876,-12%,"-$48,066",-1.0,8.0,-15.0,77.0,XOMA
317,,2013-07-01 16:24:10,2013-06-28,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$3.45,567,8523,+7%,"+$1,955",0.0,5.0,48.0,89.0,XOMA
318,D,2013-06-18 19:48:41,2013-06-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$2.36,3130,7956,+65%,"+$7,387",-5.0,-13.0,22.0,37.0,XOMA
319,D,2013-06-18 19:48:41,2013-06-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$0.00,-6000,7956,-43%,-$0,-5.0,-13.0,22.0,37.0,XOMA
320,D,2013-06-18 19:33:10,2013-06-17,XOMA,Varian John,"Dir, CEO",M - OptEx,$1.24,10000,73876,+16%,"+$12,400",-5.0,-13.0,22.0,37.0,XOMA
321,D,2013-06-18 19:33:10,2013-06-17,XOMA,Varian John,"Dir, CEO",S - Sale+OE,$0.00,-10000,73876,-12%,-$0,-5.0,-13.0,22.0,37.0,XOMA
322,D,2013-06-12 16:13:48,2013-06-11,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",M - OptEx,$1.69,10000,42590,+31%,"+$16,900",1.0,-4.0,-2.0,47.0,XOMA
323,D,2013-06-12 16:13:48,2013-06-11,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale+OE,$0.00,-10000,42590,-19%,-$0,1.0,-4.0,-2.0,47.0,XOMA
324,D,2013-05-29 18:46:17,2013-05-28,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$0.00,4667,10826,+76%,+$0,3.0,-1.0,-11.0,1.0,XOMA
325,D,2013-05-29 18:46:17,2013-05-29,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$4.16,-1797,10826,-14%,"-$7,476",3.0,-1.0,-11.0,1.0,XOMA
326,D,2013-05-29 16:20:59,2013-05-28,XOMA,Wyszomierski Jack L,Dir,M - OptEx,$2.69,2800,7299,+62%,"+$7,532",3.0,-1.0,-11.0,1.0,XOMA
327,D,2013-05-29 16:20:41,2013-05-28,XOMA,Walbert Timothy P,Dir,M - OptEx,$0.00,2800,7299,+62%,+$0,3.0,-1.0,-11.0,1.0,XOMA
328,D,2013-05-29 16:20:04,2013-05-28,XOMA,Van Ness W Denman,Dir,M - OptEx,$0.00,3150,12656,+33%,+$0,3.0,-1.0,-11.0,1.0,XOMA
329,D,2013-05-29 16:19:39,2013-05-28,XOMA,Bowes William K Jr,Dir,M - OptEx,$0.00,2800,9370,+43%,+$0,3.0,-1.0,-11.0,1.0,XOMA
330,D,2013-05-24 17:14:37,2013-05-23,XOMA,Baker Bros Advisors LLC,"Dir, 10%",A - Grant,$0.00,25200,489039,+5%,+$0,3.0,2.0,-18.0,-6.0,XOMA
331,D,2013-05-21 19:24:00,2013-05-20,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$2.36,785,7956,+11%,"+$1,853",-5.0,1.0,-13.0,0.0,XOMA
332,D,2013-05-21 19:24:00,2013-05-20,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$0.54,-6000,7956,-43%,"-$3,266",-5.0,1.0,-13.0,0.0,XOMA
333,D,2013-05-15 19:19:49,2013-05-14,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",M - OptEx,$1.69,10000,42590,+31%,"+$16,900",0.0,-1.0,-4.0,-12.0,XOMA
334,D,2013-05-15 19:19:49,2013-05-14,XOMA,Scannon Patrick J Md Phd,"EVP, CSO",S - Sale+OE,$0.00,-10000,42590,-19%,-$0,0.0,-1.0,-4.0,-12.0,XOMA
335,D,2013-05-15 19:15:18,2013-05-15,XOMA,Varian John,"Dir, CEO",M - OptEx,$1.24,10000,73876,+16%,"+$12,400",0.0,-1.0,-4.0,-12.0,XOMA
336,D,2013-05-15 19:15:18,2013-05-15,XOMA,Varian John,"Dir, CEO",S - Sale+OE,$0.00,-10000,73876,-12%,-$0,0.0,-1.0,-4.0,-12.0,XOMA
337,,2013-04-19 16:55:41,2013-04-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale,$0.00,-6000,13171,-31%,-$0,-2.0,1.0,24.0,38.0,XOMA
338,,2013-04-01 16:59:27,2013-03-28,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$3.32,1498,19171,+8%,"+$4,967",2.0,2.0,5.0,31.0,XOMA
339,D,2013-03-27 17:31:06,2013-03-18,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$0.00,18205,17673,-3422%,+$0,0.0,-5.0,-1.0,29.0,XOMA
340,D,2013-03-27 17:31:06,2013-03-19,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",S - Sale+OE,$3.29,-6990,17673,-28%,"-$22,997",0.0,-5.0,-1.0,29.0,XOMA
341,,2013-01-02 16:57:01,2012-12-31,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$2.28,833,4244,+24%,"+$1,899",5.0,16.0,4.0,46.0,XOMA
342,D,2012-11-15 10:02:41,2012-11-13,XOMA,Wyszomierski Jack L,Dir,M - OptEx,$0.00,4499,4499,New,+$0,-2.0,4.0,-2.0,58.0,XOMA
343,D,2012-11-15 10:02:15,2012-11-13,XOMA,Walbert Timothy P,Dir,M - OptEx,$0.00,4499,4499,New,+$0,-2.0,4.0,-2.0,58.0,XOMA
344,D,2012-11-15 10:01:59,2012-11-13,XOMA,Varian John,"Dir, CEO",M - OptEx,$0.00,100666,69421,-322%,+$0,-2.0,4.0,-2.0,58.0,XOMA
345,D,2012-11-15 10:01:59,2012-11-14,XOMA,Varian John,"Dir, CEO",S - Sale+OE,$2.56,-40587,69421,-37%,"-$103,807",-2.0,4.0,-2.0,58.0,XOMA
346,D,2012-11-15 10:01:51,2012-11-13,XOMA,Van Ness W Denman,Dir,M - OptEx,$0.00,6876,9506,+261%,+$0,-2.0,4.0,-2.0,58.0,XOMA
347,D,2012-11-15 10:01:12,2012-11-13,XOMA,Scannon Patrick J Md Phd,EVP,M - OptEx,$0.00,22653,38135,+146%,+$0,-2.0,4.0,-2.0,58.0,XOMA
348,D,2012-11-15 10:01:12,2012-11-14,XOMA,Scannon Patrick J Md Phd,EVP,S - Sale+OE,$2.56,-8773,38135,-19%,"-$22,445",-2.0,4.0,-2.0,58.0,XOMA
349,D,2012-11-15 10:01:03,2012-11-13,XOMA,Kurland Fred,"CFO, VP Finance",M - OptEx,$0.00,22596,31426,+256%,+$0,-2.0,4.0,-2.0,58.0,XOMA
350,D,2012-11-15 10:01:03,2012-11-14,XOMA,Kurland Fred,"CFO, VP Finance",S - Sale+OE,$2.56,-9111,31426,-22%,"-$23,310",-2.0,4.0,-2.0,58.0,XOMA
351,D,2012-11-15 10:00:38,2012-11-13,XOMA,Bowes William K Jr,Dir,M - OptEx,$0.00,4499,6570,+217%,+$0,-2.0,4.0,-2.0,58.0,XOMA
352,,2012-10-31 17:02:29,2012-10-29,XOMA,Baker Julian,"Dir, 10%",P - Purchase,$3.00,4722666,480639,-111%,"+$14,167,998",3.0,1.0,10.0,19.0,XOMA
353,,2012-10-01 18:02:37,2012-09-28,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$3.51,542,3411,+19%,"+$1,900",-2.0,-1.0,-25.0,-5.0,XOMA
354,D,2012-07-23 17:04:04,2012-07-19,XOMA,Neu Kelvin,Dir,A - Grant,$0.00,16800,16800,New,+$0,0.0,8.0,-8.0,-21.0,XOMA
355,,2012-07-02 17:52:41,2012-06-15,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",G - Gift,$0.00,-3887,2869,-58%,-$0,15.0,30.0,21.0,-14.0,XOMA
356,,2012-07-02 17:52:41,2012-06-29,XOMA,Rubin Paul D,"SVP Clinical Dev., CMO",M - OptEx,$2.83,661,2869,+30%,"+$1,871",15.0,30.0,21.0,-14.0,XOMA
357,,2012-04-02 16:09:27,2012-03-30,XOMA,Rubin Paul D,"VP Clinical Dev., CMO",M - OptEx,$2.63,1229,6095,+25%,"+$3,234",0.0,-4.0,6.0,34.0,XOMA
358,,2011-11-16 14:56:07,2011-11-11,XOMA,Van Ness W Denman,Dir,S - Sale,$1.60,-698,2630,-21%,"-$1,117",-4.0,-9.0,-23.0,52.0,XOMA
359,,2011-10-03 16:52:45,2011-09-30,XOMA,Rubin Paul D,"VP Clinical Dev., CMO",M - OptEx,$1.66,1022,1022,New,"+$1,699",4.0,12.0,6.0,70.0,XOMA
360,,2011-03-28 17:47:13,2011-03-25,XOMA,Kurland Fred,"CFO, VP Finance",P - Purchase,$3.26,5000,8417,+146%,"+$16,320",-5.0,-2.0,-2.0,-37.0,XOMA
361,A,2007-08-27 17:49:45,2007-08-17,XOMA,Kornberg Arthur Md,Dir,M - OptEx,$1.56,20000,20000,New,"+$31,100",18.0,21.0,53.0,11.0,XOMA
362,,2007-03-15 18:02:39,2007-03-15,XOMA,Scannon Patrick J Md Phd,EVP,A - Grant,$3.19,8193,151500,+6%,"+$26,136",1.0,4.0,13.0,10.0,XOMA
363,,2007-03-15 18:02:28,2007-03-15,XOMA,Margolin Christopher J,"VP, GC, Sec'y",A - Grant,$3.19,6314,101183,+7%,"+$20,142",1.0,4.0,13.0,10.0,XOMA
364,,2007-03-15 18:02:16,2007-03-15,XOMA,Castello John L,"Pres, CEO and",A - Grant,$3.19,21475,190607,+13%,"+$68,505",1.0,4.0,13.0,10.0,XOMA
365,,2007-03-15 18:02:03,2007-03-15,XOMA,Boyle J David II,"VP, Finance,, CFO",A - Grant,$3.19,5195,18934,+38%,"+$16,572",1.0,4.0,13.0,10.0,XOMA
366,,2006-03-15 18:20:13,2006-03-15,XOMA,Scannon Patrick J Md Phd,CSMO,A - Grant,$1.69,11798,138681,+9%,"+$19,986",1.0,-2.0,5.0,-12.0,XOMA
367,,2006-03-15 18:20:03,2006-03-15,XOMA,Margolin Christopher J,"VP, GC, Sec'y",A - Grant,$1.69,13728,90243,+18%,"+$23,255",1.0,-2.0,5.0,-12.0,XOMA
368,,2006-03-15 18:19:51,2006-03-15,XOMA,Castello John L,"Pres, CEO and",A - Grant,$1.69,30376,153394,+25%,"+$51,457",1.0,-2.0,5.0,-12.0,XOMA
369,,2006-03-15 18:19:41,2006-03-15,XOMA,Boyle J David II,"VP, Finance,, CFO",A - Grant,$1.69,8739,13739,+175%,"+$14,804",1.0,-2.0,5.0,-12.0,XOMA
370,,2005-08-17 18:21:34,2005-08-17,XOMA,Boyle J David II,"VP, Finance,, CFO",P - Purchase,$1.44,5000,5000,New,"+$7,200",2.0,10.0,26.0,20.0,XOMA
371,,2005-05-12 13:49:15,2005-05-11,XOMA,Dellio Clarence L,"SVP, Operations, COO",S - Sale,$1.41,-10974,117432,-9%,"-$15,491",0.0,0.0,44.0,22.0,XOMA
372,,2005-03-31 20:56:23,2005-03-30,XOMA,Margolin Christopher J,"VP, GC, Sec'y",S - Sale,$1.03,-53700,71199,-43%,"-$55,472",-1.0,28.0,17.0,73.0,XOMA
373,,2005-03-16 15:46:21,2005-03-15,XOMA,Scannon Patrick J Md Phd,CSMO,A - Grant,$1.43,18319,121568,+18%,"+$26,105",-7.0,-8.0,-4.0,55.0,XOMA
374,,2005-03-16 15:46:12,2005-03-15,XOMA,Margolin Christopher J,"VP, GC, Sec'y",A - Grant,$1.43,13661,124899,+12%,"+$19,467",-7.0,-8.0,-4.0,55.0,XOMA
375,,2005-03-16 15:46:03,2005-03-15,XOMA,Dellio Clarence L,"SVP, Operations, COO",A - Grant,$1.43,13753,128406,+12%,"+$19,598",-7.0,-8.0,-4.0,55.0,XOMA
376,,2005-03-16 15:45:53,2005-03-15,XOMA,Davis Peter B,"VP, Finance, CFO",A - Grant,$1.43,15589,135621,+13%,"+$22,214",-7.0,-8.0,-4.0,55.0,XOMA
377,,2005-03-16 15:45:40,2005-03-15,XOMA,Castello John L,"Pres, CEO and",A - Grant,$1.43,31784,111141,+40%,"+$45,292",-7.0,-8.0,-4.0,55.0,XOMA
378,,2004-09-20 12:38:46,2004-09-17,XOMA,Dellio Clarence L,"SVP, Operations, COO",S - Sale,$2.51,-4294,111589,-4%,"-$10,778",-3.0,-13.0,-18.0,-57.0,XOMA
379,,2004-09-14 16:45:46,2004-08-02,XOMA,Van Ness W Denman,Dir,W - Inherited,$0.00,680,50611,-1%,$0,-3.0,-2.0,-14.0,-54.0,XOMA
380,,2004-07-01 16:45:41,2004-06-30,XOMA,Dellio Clarence L,"SVP, Operations, COO",S - Sale,$4.75,-4000,115883,-3%,"-$19,000",-2.0,-9.0,-21.0,-48.0,XOMA
381,,2004-05-24 18:10:44,2004-05-21,XOMA,Andress James G,Dir,P - Purchase,$3.99,2000,2000,New,"+$7,980",1.0,5.0,2.0,-48.0,XOMA
382,,2004-05-11 19:47:53,2004-05-10,XOMA,Castello John L,"COB, CEO, Pres",G - Gift,$3.89,-15000,71015,-17%,"-$58,350",9.0,-3.0,3.0,-49.0,XOMA
383,D,2004-05-11 19:47:24,2004-05-10,XOMA,Bowes William K Jr,Dir,M - OptEx,$3.38,1000,31069,+3%,"+$3,380",9.0,-3.0,3.0,-49.0,XOMA
384,D,2004-05-11 19:47:13,2004-05-07,XOMA,Kornberg Arthur Md,Dir,M - OptEx,$3.38,1000,11000,+10%,"+$3,380",9.0,-3.0,3.0,-49.0,XOMA
385,D,2004-04-14 19:38:27,2004-04-13,XOMA,Mendell Steven C,Dir,M - OptEx,$3.38,1000,40631,+3%,"+$3,380",0.0,-6.0,-12.0,-54.0,XOMA
386,D,2004-04-14 19:38:27,2004-04-13,XOMA,Mendell Steven C,Dir,S - Sale+OE,$4.88,-1000,40631,-2%,"-$4,880",0.0,-6.0,-12.0,-54.0,XOMA
387,D,2004-04-14 19:37:19,2004-04-13,XOMA,Scannon Patrick J Md Phd,CSMO,M - OptEx,$2.50,75000,100185,+298%,"+$187,500",0.0,-6.0,-12.0,-54.0,XOMA
388,D,2004-04-14 19:37:19,2004-04-13,XOMA,Scannon Patrick J Md Phd,CSMO,S - Sale+OE,$4.97,-75000,100185,-43%,"-$373,028",0.0,-6.0,-12.0,-54.0,XOMA
389,,2004-03-31 19:22:24,2004-03-31,XOMA,Castello John L,"COB, CEO, Pres",A - Grant,$4.37,677,86015,+1%,"+$2,958",5.0,3.0,-14.0,-57.0,XOMA
390,,2004-03-25 17:55:43,2004-03-25,XOMA,Davis Peter B,"VP, Finance, CFO",P - Purchase,$4.79,5000,109946,+5%,"+$23,928",0.0,11.0,1.0,-51.0,XOMA
391,,2004-03-17 15:20:20,2004-03-15,XOMA,Scannon Patrick J Md Phd,CSMO,A - Grant,$6.45,2167,100185,+2%,"+$13,986",-4.0,-20.0,-11.0,-54.0,XOMA
392,,2004-03-17 15:20:05,2004-03-15,XOMA,Margolin Christopher J,"VP, GC, Sec'y",A - Grant,$6.45,1684,94635,+2%,"+$10,869",-4.0,-20.0,-11.0,-54.0,XOMA
393,,2004-03-17 15:19:57,2004-03-15,XOMA,Dellio Clarence L,"SVP, Operations, COO",A - Grant,$6.45,5735,119883,+5%,"+$37,014",-4.0,-20.0,-11.0,-54.0,XOMA
394,,2004-03-17 15:19:20,2004-03-15,XOMA,Davis Peter B,"VP, Finance, CFO",A - Grant,$6.45,4736,104946,+5%,"+$30,566",-4.0,-20.0,-11.0,-54.0,XOMA
395,D,2004-01-12 19:02:16,2004-01-09,XOMA,Margolin Christopher J,"VP, GC, Sec'y",M - OptEx,$2.50,75000,92951,+418%,"+$187,500",1.0,3.0,-6.0,-42.0,XOMA
396,D,2004-01-12 19:02:16,2004-01-09,XOMA,Margolin Christopher J,"VP, GC, Sec'y",S - Sale+OE,$7.56,-40000,92951,-30%,"-$302,416",1.0,3.0,-6.0,-42.0,XOMA
397,,2004-01-12 19:01:47,2004-01-09,XOMA,Dellio Clarence L,"SVP, Operations, COO",S - Sale,$7.49,-15969,114148,-12%,"-$119,608",1.0,3.0,-6.0,-42.0,XOMA
398,D,2004-01-05 14:06:17,2004-01-02,XOMA,Dellio Clarence L,"SVP, Operations, COO",M - OptEx,$2.56,23969,130117,+23%,"+$61,421",0.0,11.0,6.0,-35.0,XOMA
399,D,2003-12-23 20:34:40,2003-12-23,XOMA,Scannon Patrick J Md Phd,CSMO,M - OptEx,$2.56,105000,96964,-1307%,"+$269,063",0.0,-1.0,8.0,-39.0,XOMA
400,D,2003-12-23 20:34:40,2003-12-23,XOMA,Scannon Patrick J Md Phd,CSMO,S - Sale+OE,$6.54,-105000,96964,-52%,"-$686,977",0.0,-1.0,8.0,-39.0,XOMA
401,,2003-11-05 13:17:53,2003-11-03,XOMA,Castello John L,"COB, CEO, Pres",G - Gift,$7.18,-7500,84284,-8%,"-$53,850",-1.0,-5.0,-7.0,-43.0,XOMA
